v3.26.1
Condensed Consolidated Statements of Changes in Stockholders Equity (Unaudited) - USD ($)
$ in Thousands
Total
Numed
Renergen
Common Stock
Common Stock
Numed
Common Stock
Renergen
Treasury Stock
Treasury Stock
Numed
Treasury Stock
Renergen
Additional Paid-In Capital
Additional Paid-In Capital
Numed
Additional Paid-In Capital
Renergen
Accumulated Other Comprehensive (Loss) Income
Accumulated Other Comprehensive (Loss) Income
Numed
Accumulated Other Comprehensive (Loss) Income
Renergen
Accumulated Deficit
Accumulated Deficit
Numed
Accumulated Deficit
Renergen
Noncontrolling Interest
Noncontrolling Interest
Numed
Noncontrolling Interest
Renergen
Balance, shares at Dec. 31, 2024       72,068,059                                  
Balance, amount at Dec. 31, 2024 $ 51,167     $ 721     $ 0     $ 105,515     $ (2,164)     $ (56,173)     $ 3,268    
Stock-based compensation expense 1,890     0     0     1,890     0     0     0    
Distribution to noncontrolling interest of Renergen 0                                        
Distribution to noncontrolling interest of VIE (38)     0     0     0     0     0     (38)    
Foreign currency translation 1,171     0     0     0     1,171     0     0    
Net loss - continuing operations (8,461)                                        
Net loss (8,461)     $ 0     0     0     0     (8,446)     (15)    
Balance, shares at Mar. 31, 2025       72,068,059                                  
Balance, amount at Mar. 31, 2025 45,729     $ 721     0     107,405     (993)     (64,619)     3,215    
Balance, shares at Dec. 31, 2025       111,677,771                                  
Balance, amount at Dec. 31, 2025 262,898     $ 1,117     $ 0     431,757     2,542     (231,265)     58,747    
Issuance of common stock to acquire Renergen, shares           14,270,000                              
Issuance of common stock to acquire Renergen     $ 92,897     $ 142     $ 0     $ 92,755     $ 0     $ 0     $ 0
Forfeiture of restricted common stock, shares       44,324     44,324                            
Forfeiture of restricted common stock 0     $ 0     $ 0     0     0     0     0    
Stock-based compensation expense 4,412     0     0     4,412     0     0     0    
Deconsolidation of subsidiary (86,783)     0     0     0     (9)     0     (86,774)    
Fair value of noncontrolling interest at acquisition   $ 597 7,276   $ 0 0   $ 0 0   $ 0 0   $ 0 0   $ 0 0   $ 597 7,276
Distribution to noncontrolling interest of Renergen 380   $ (380)     $ 0     $ 0     $ 0     $ 0     $ (380)     $ 0
Contributions from noncontrolling interest 26,960     0     0     0     0     0     26,960    
Distribution to noncontrolling interest of VIE (257)     0     0     0     0     0     (257)    
Foreign currency translation (6,259)     0     0     0     (6,688)     0     429    
Reclassification to earnings 0     0     0     0     1,496     (1,496)     0    
Net loss - continuing operations (26,706)     0     0     0     0     (26,463)     (243)    
Gain on deconsolidation 20,832     0     0     0     0     20,832     0    
Net income - discontinued operations 3,530     $ 0     $ 0     0     0     249     3,281    
Net loss (7,121)                                        
Balance, shares at Mar. 31, 2026             44,324                            
Balance, shares at Mar. 31, 2026       125,903,447                                  
Balance, amount at Mar. 31, 2026 $ 299,017     $ 1,259     $ 0     $ 528,924     $ (2,659)     $ (238,523)     $ 10,016